
Aktiviere Job-Benachrichtigungen per E-Mail!
Erstelle in nur wenigen Minuten einen maßgeschneiderten Lebenslauf
Überzeuge Recruiter und verdiene mehr Geld. Mehr erfahren
A leading research university is offering a PhD position in Immunology focused on the yellow fever vaccine's immune response using multi-omics approaches. The role involves designing experiments, analyzing data, and collaborating across disciplines. Candidates should have a Master’s in a related field and experience in Immunology is preferred. This position offers a modern laboratory environment and opportunities for professional growth and participation in an international research project, with an application deadline of February 1, 2026.
Ludwig‑Maximilians‑Universität München is a leading research university in Europe. Since its founding in 1472 it has been committed to the highest international standards of excellence in research and teaching.
Institution: Faculty of Medicine – Biomedical Center (BMC), Institute for Immunology. Remuneration group TV‑L E13; Full‑time / Part‑time (65%). Start date: earliest convenience. Application deadline: 2026‑02‑01.
LMU Munich is one of Europe’s leading research institutions. Scientists from all over the world encounter excellent conditions for their work – in their own research field and in interdisciplinary networks alike. The Institute for Immunology is part of the Biomedical Center (BMC) of the LMU Faculty of Medicine. Research in the Krug lab is dedicated to elucidating developmental and functional diversity of dendritic cell (DC) subpopulations in the context of viral infection and vaccination. The BMC is located on the Martinsried Campus of the LMU and offers an ideal research infrastructure with close proximity to the LMU University Hospital, the Faculties of Chemistry, Pharmacy and Biology, and several other research institutions. Off campus, Munich is one of the friendliest and liveliest cities in the world and offers a wide range of cultural and leisure activities all year round.
The YF vaccine is the most successful live‑attenuated vaccine available and provides long‑lasting immune protection after a single dose. The exact mechanisms governing its immunogenicity and efficacy remain to be fully elucidated. This PhD position focuses on investigating the spatial and temporal coordination of the early immune response to the live‑attenuated yellow fever vaccine at the injection site in human skin using a multi‑omics approach, including transcriptomics and targeted proteomics. A specific focus will be placed on cell‑cell communication and antigen delivery to dendritic cells for initiating adaptive immunity as determinants of vaccine effectiveness, involving primary cell culture experiments with dendritic cells. The project is integrated into the EU‑funded consortium Yellow4FLAVI: “Deconstructing the protective immunity of yellow fever virus 17D to inform flavivirus vaccine design”.
PhD position – Immunology (m/f/x) – in Planegg.
We welcome applications from all backgrounds. The promotion of diversity is an important strategic goal at our center, reflected in the BMC Code of Conduct, which actively promotes diversity and equal opportunities. People with disabilities who are equally as qualified as other applicants will receive preferential treatment.
Do you have questions about visa requirements or degree recognition? Are you looking for housing, childcare, or trying to decide on the best health insurance? The “Research in Bavaria” and LMU Gateway websites provide help in these practical matters.
Please submit your complete application exclusively via our online application tool, including the following documents individually as PDF files:
AI policy: AI assistance is welcome for tasks like proofreading, but you must clearly mention where it was used. Primarily AI‑generated applications will be automatically discarded without feedback.
Applications will be considered if submitted by January 15th, 2026.
Ludwig‑Maximilians‑Universität München
Geschwister‑Scholl‑Platz 1
80539 München
www.lmu.de